Haematological improvement as a beneficial effect during deferasirox treatment in transfusion-dependent patients with myelodysplastic syndrome

被引：6
|
作者：
Molica, Matteo [1 ]
Salaroli, Adriano [1 ]
Alimena, Giuliana [1 ]
Breccia, Massimo [1 ]
机构：
[1] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, I-00161 Rome, Italy
来源：
BLOOD TRANSFUSION | 2014年 / 12卷
关键词：
D O I：
10.2450/2013.0005-13
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S162 / S163
页数：2
相关论文
共 50 条
  • [41] Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study
    Gattermann, Norbert
    Finelli, Carlo
    Della Porta, Matteo
    Fenaux, Pierre
    Ganser, Arnold
    Guerci-Bresler, Agnes
    Schmid, Mathias
    Taylor, Kerry
    Vassilieff, Dominique
    Habr, Dany
    Domokos, Gabor
    Roubert, Bernard
    Rose, Christian
    LEUKEMIA RESEARCH, 2010, 34 (09) : 1143 - 1150
  • [42] EFFICACY OF ORAL DEFERASIROX BY TWICE-DAILY DOSING IN PATIENTS WITH TRANSFUSION-DEPENDENT β-THALASSAEMIA
    Salehifar, Ebrahim
    Karami, Hosein
    Kosaryan, Mehrnoosh
    Masoudi, Hosein
    Aliasgharian, Aily
    Mousavi, Masoumeh
    Avan, Razieh
    HAEMATOLOGICA, 2017, 102 : 85 - 85
  • [43] Evaluation of Azacitidine in Transfusion-Dependent, Epo-Refractory Patients with Lower-Risk Myelodysplastic Syndrome
    Tobiasson, Magnus
    Brandefors, Lena
    Dybedal, Ingunn
    Garelius, Hege
    Grovdal, Michael
    Dufva, Inge Hoegh
    Kjeldsen, Lars
    Nilsson, Lars
    Kittang, Astrid Olsnes
    Porwit, Anna
    Saft, Leonie
    Holm, Mette Skov
    Mollgard, Lars
    Hellstrom-Lindberg, Eva
    BLOOD, 2011, 118 (21) : 1622 - 1623
  • [44] Urinary Metabolic Profile of Patients with Transfusion-Dependent β-Thalassemia Major Undergoing Deferasirox Therapy
    Capolongo, Giovanna
    Zacchia, Miriam
    Beneduci, Amerigo
    Costantini, Silvia
    Cinque, Patrizia
    Spasiano, Anna
    De Luca, Giuseppina
    Di Pietro, Maria Enrica
    Ricchi, Paolo
    Trepiccione, Francesco
    Capasso, Giovambattista
    Filosa, Aldo
    KIDNEY & BLOOD PRESSURE RESEARCH, 2020, 45 (03): : 455 - 466
  • [45] Effect of Aging on Deferasirox Therapy in Transfusion-dependent Patients. A Prospective-Retrospective, Cohort-study
    Marini, Valeria
    Pinto, Valeria Maria
    Stella, Manuela
    Fucile, Carmen
    Lantieri, Francesca
    Luci, Giacomo
    Gianesin, Barbara
    Bacigalupo, Lorenzo
    Forni, Gian Luca
    Mattioli, Francesca
    CURRENT DRUG METABOLISM, 2022, 23 (13) : 1072 - 1079
  • [46] Do ESAs Reduce Transfusion Need among Transfusion-Dependent Myelodysplastic Syndromes (MDS) Patients?
    Smith, Sheila R. Weiss
    Sato, Masayo
    Baer, Maria R.
    Ke, Xuehua
    Gore, Steven D.
    Davidoff, Amy
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S282 - S283
  • [47] Mayor Erythropoietic Response after Deferasirox Treatment in a Transfusion-Dependent Anemic Patient with Primary Myelofibrosis
    Lisette, Del Corso
    Enrico, Balleari
    Eleonora, Arboscello
    Riccardo, Ghio
    Manilo, Mencoboni
    Omar, Racchi
    CASE REPORTS IN HEMATOLOGY, 2013, 2013
  • [48] Dose Dependent Effect of Deferasirox on Hematopoietic Progeneitors of Myelodysplastic Syndrome.
    Pullarkat, Vinod
    Sehgal, Arjun
    Li, Liang
    Lin, Allen
    Forman, Stephen J.
    Bhatia, Ravi
    BLOOD, 2010, 116 (21) : 1627 - 1628
  • [49] Cost of transfusion-dependent myelodysplastic syndrome (MDS) from a German payer's perspective
    Kuehne, Felicitas
    Mittendorf, Thomas
    Germing, Ulrich
    Tesch, Hans
    Weinberg, Reiner
    Grabenhorst, Ulrich
    Mohr, Andreas
    Lipp, Rainer
    von der Schulenburg, Johann Matthias
    ANNALS OF HEMATOLOGY, 2010, 89 (12) : 1239 - 1247
  • [50] De-Iron: a phase 2 trial of the activity and safety of Deferasirox administered at early iron loading in patients with transfusion-dependent myelodysplastic syndromes
    Killick, Sally
    Jackson, Aimee
    Coulthard, Helen C.
    Yap, Christina
    Das-Gupta, Emma
    Pennell, Dudley J.
    Porter, John
    Bowen, David
    Culligan, Dominic
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (06) : E237 - E240
12345